ARISg is the world's leading pharmacovigilance and clinical safety system for good reason, with more than 300 life-science companies maintaining their critical safety data in ARISg worldwide. ARISg is the adverse event reporting software that provides all the functionality required to meet your regulatory obligations, from case entry to compliance tracking
ARISg is the core component of an integrated pharmacovigilance and risk management strategy, enabling companies to monitor their products and provide early identification of product risks and safety trends.
ARISg helps speed up information delivery with the use of its configurable workflow components. Users can set up a system that meets their business process and SOP requirements easily and more efficiently by streamlining case processing and automating the routing of cases as defined in the workflow rules.
As with all Aris Global products, ARISg is available as a hosted solution on the agOnDemand platform. For more than four years,

agOnDemand has been providing best-in-class, cloud-based services to life science companies to help them meet their regulatory requirements without the pressure of maintaining sophisticated IT infrastructures.
ARISg offers unrivaled advanced software capabilities for managing adverse drug event reaction reporting. Fully scalable, ARISg can be used by small operations in the early stages of clinical trials or large organizations with worldwide pharmacovigilance operations. Key features include:

Used in conjunction with agSignals and other components of our Total Safety suite, ARISg provides a powerful platform for developing a comprehensive pharmacovigilance and risk management strategy.
More than 300 life science companies maintaining their critical safety data in ARISg worldwide.
The following are just a few of the key benefits that ARISg delivers:
"We selected Aris Global because we found it to be the only company providing a solution capable of meeting our requirements of an integrated, comprehensive global pharmacovigilance system with proven Japanese language and regulations support"
Mr. Nassim Belhadj,
Project Manager, Pharmacovigilance, Guerbet Group Guerbet Group